Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Michiko Taniguchi"'
Autor:
Regina Jung, Kevin Ly, Michiko Taniguchi, Aileen Grace Arriola, Christopher Gravante, Derek Shinn, Leena Mathew, Eman Hamad, Steven Geier, Abdelhamid Liacini
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 4, p 2218 (2024)
HLA donor-specific antibodies (DSAs) pre and post transplant increase the risk of antibody-mediated rejection (AMR) and lead to poor graft survival. Increasing data exist to support the involvement of non-HLA antibodies in triggering an immunological
Externí odkaz:
https://doaj.org/article/c0c0c4f4f16c4783820415b71358d9c9
Autor:
Stefan O. Ciurea, Piyanuch Kongtim, Gabriela Rondon, Salman Otoukesh, Stephen J. Forman, Richard E. Champlin, Julianne Chen, Auayporn Nademanee, Michiko Taniguchi, Kai Cao, Ketevan Gendzekhadze, Fleur M. Aung, Jun Zou, Monzr M. Al Malki
Publikováno v:
Blood Advances. 5:4031-4043
Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in patients receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments are needed for these patients, who often have no other donor options an
Autor:
Benjamin P. Peton, Michiko Taniguchi, Jean F. Garcia-Gomez, Bruce Zeng, Arisa Oki, Nubia Banuelos, Wyatt C. Nelson, Randa Abou-Taleb, Monzr M. Al Malki, Ketevan Gendzekhadze
Publikováno v:
Transplantation. 106:e312-e313
Autor:
Nicole Karras, Shukaib Arslan, Haris Ali, Geoffrey Shouse, Michael R. Carter, Dongyun Yang, Ketevan Gendzekhadze, Michiko Taniguchi, Monzr M. Al Malki
Publikováno v:
Bone Marrow Transplant
Autor:
Melissa Valerio, Ketevan Gendzekhadze, Benjamin Peton, Michiko Taniguchi, Ebtsesam Nafie, Ivan Rodriguez, Monzr M. Al Malki, Guido Marcucci, Lucy Ghoda
Publikováno v:
Blood. 138:3990-3990
Note: BP, MV and LG, KG contributed equally Background Relapsed acute myeloid leukemia (AML) remains the most common reason for allogeneic hematopoietic cell transplant (HCT) failure. Thus, understanding AML immune escape mechanism is important for i
Autor:
Satoshi Umemura, Tomoyuki Murakami, Michiko Taniguchi, Gen Yasuda, Akira Fujiwara, Tamio Iwamoto, Nobuhito Hirawa
Publikováno v:
Clinical and Experimental Nephrology. 20:603-610
Few studies have examined how renin–angiotensin system inhibitors (RASI) delay dialysis initiation in patients with advanced chronic kidney disease (CKD). We conducted a retrospective survey to examine this subject. We reviewed the records of patie
Autor:
Hidenori Ohe, Kimiko Yurugi, Atsushi Yoshizawa, Michiko Taniguchi, Yoichiro Uchida, Taira Maekawa, Shinji Uemoto, Rie Hishida, Etsuko Maruya, Hirofumi Hirao, Paul I. Terasaki
Publikováno v:
Transplantation. 98:1105-1111
BACKGROUND Many pediatric patients who receive a living-donor liver transplant undergo withdrawal of immunosuppression (IS). For them, the high incidence of long-term progressive graft fibrosis is of particular concern. METHODS We conducted a cross-s
Autor:
Michiko, Taniguchi, Lorita M, Rebellato, Kimberly P, Briley, Carl E, Haisch, Paul, Bolin, Nubia, Banuelos, Judy, Hopfield, Paul I, Terasaki, Matthew J, Everly
Publikováno v:
Clinical transplants. 31
Human leukocyte antigen (HLA) antibodies are a major cause of graft loss in mismatched transplant recipients. However, the time to graft loss resulting from antibody induced injury is unpredictable. The unpredictable nature of antibodies may be relat
Publikováno v:
Human Immunology. 79:67-68
Aim To investigate observations of high rates of discrepancies between virtual crossmatch (VXM) positive and flow cytometry crossmatch (FCXM) negative cases in the presence of HLA-B13 DSA. Methods Sera with antibodies against HLA-B*13:01 and/or B*13: